These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34459091)

  • 1. YAP-induced Ccl2 expression is associated with a switch in hepatic macrophage identity and vascular remodelling in liver cancer.
    Thomann S; Weiler SME; Wei T; Sticht C; De La Torre C; Tóth M; Rose F; Tang Y; Ritz T; Ball C; Glimm H; Ryschich E; Schirmacher P; Breuhahn K
    Liver Int; 2021 Dec; 41(12):3011-3023. PubMed ID: 34459091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
    Thomann S; Weiler SME; Marquard S; Rose F; Ball CR; Tóth M; Wei T; Sticht C; Fritzsche S; Roessler S; De La Torre C; Ryschich E; Ermakova O; Mogler C; Kazdal D; Gretz N; Glimm H; Rempel E; Schirmacher P; Breuhahn K
    Cancer Res; 2020 Dec; 80(24):5502-5514. PubMed ID: 33087321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CCR2
    Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
    Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL2-CCR2 signaling promotes hepatic ischemia/reperfusion injury.
    Zhang J; Xu P; Song P; Wang H; Zhang Y; Hu Q; Wang G; Zhang S; Yu Q; Billiar TR; Wang C; Zhang J
    J Surg Res; 2016 May; 202(2):352-62. PubMed ID: 27229110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages.
    Du L; Ji Y; Xin B; Zhang J; Lu LC; Glass CK; Feng GS
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1351-1369. PubMed ID: 36828281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
    Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K
    Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STC1 competitively binding βPIX enhances melanoma progression via YAP nuclear translocation and M2 macrophage recruitment through the YAP/CCL2/VEGFA/AKT feedback loop.
    Ren Z; Xu Z; Chang X; Liu J; Xiao W
    Pharmacol Res; 2024 Jun; 204():107218. PubMed ID: 38768671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
    Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
    J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
    Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
    PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1 Promotes Macrophage Recruitment via Activation of NF-
    Chen J; Ji K; Gu L; Fang Y; Pan M; Tian S
    J Immunol Res; 2022; 2022():4727198. PubMed ID: 35785026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of SLFN11 Deficiency-Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti-PD-1 Therapy Efficacy in Hepatocellular Carcinoma.
    Zhou C; Weng J; Liu C; Liu S; Hu Z; Xie X; Gao D; Zhou Q; Sun J; Xu R; Li H; Shen Y; Yi Y; Shi Y; Sheng X; Dong Q; Hung MC; Ren N
    Gastroenterology; 2023 Jun; 164(7):1261-1278. PubMed ID: 36863689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
    Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
    Front Immunol; 2022; 13():993444. PubMed ID: 36685592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.